BAX and osteosarcoma: However, compared with drug-resistant osteosarcoma cells, overexpression of miR-506-3p or silencing of STAT3 decreased the expression of Bcl-2 and increased the expression of Bax, which in turn led to a decrease in the Bcl-2/Bax ratio.